NCT05659719View on ClinicalTrials.gov

A Study to Learn About Recifercept in Patients With Achondroplasia

CompletedOBSERVATIONAL

Enrollment

248

Participants

Timeline

Start Date

October 19, 2022

Primary Completion Date

May 16, 2023

Study Completion Date

May 16, 2023

Conditions

Achondroplasia

Interventions

OTHER

Recifercept

Patients received recifercept intervention in the phase 2 clinical trial

Trial Locations (1)

10017

Pfizer, New York

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY